Symptom trajectories in patients with panic disorder in a primary care intervention: Results from a randomized controlled trial (PARADISE).
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
09 05 2019
09 05 2019
Historique:
received:
25
01
2019
accepted:
24
04
2019
entrez:
11
5
2019
pubmed:
11
5
2019
medline:
21
10
2020
Statut:
epublish
Résumé
This analysis aims to identify and characterize symptom trajectories in primary care patients with panic disorder with/without agoraphobia (PD/AG) who participated in a primary care team based training involving elements of cognitive behavioural therapy (CBT). Growth Mixture Modeling was used to identify different latent classes of change in patients with PD/AG (N = 176) who underwent treatment including CBT elements. We identified three patient classes with distinct similar trajectories. Class 1 (n = 58, mean age: 46.2 years ± 13.4 years, 81% women) consisted of patients with an initially high symptom burden, but symptoms declined constantly over the intervention period. Symptoms of patients in class 2 (n = 89, mean age: 44.2 years ± 14.5 years, 67.4% women) declined rapidly at the beginning, then patients went into a plateau-phase. The third class (n = 29, mean age: 47.0 years ± 12.4 years, 65.5% women) was characterized by an unstable course and had the worse outcome. Our findings show that only a minority did not respond to the treatment. To identify this minority and refer to a specialist would help patients to get intensive care in time.
Identifiants
pubmed: 31073189
doi: 10.1038/s41598-019-43487-x
pii: 10.1038/s41598-019-43487-x
pmc: PMC6509250
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
7170Références
Behav Res Ther. 1993 Jan;31(1):1-8
pubmed: 8093337
Annu Rev Clin Psychol. 2007;3:1-27
pubmed: 17716046
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Trials. 2014 Apr 06;15:112
pubmed: 24708672
Health Aff (Millwood). 2001 Nov-Dec;20(6):64-78
pubmed: 11816692
J Consult Clin Psychol. 1997 Aug;65(4):673-85
pubmed: 9256569
Psychother Psychosom. 2013;82(1):20-34
pubmed: 23147126
Dtsch Arztebl Int. 2019 Mar 8;116(10):159-166
pubmed: 30995952
Eur Neuropsychopharmacol. 2011 Sep;21(9):655-79
pubmed: 21896369
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
J Consult Clin Psychol. 2005 Oct;73(5):904-13
pubmed: 16287390
Arch Gen Psychiatry. 1998 Apr;55(4):334-43
pubmed: 9554429
J Affect Disord. 2009 Jan;112(1-3):92-101
pubmed: 18486238
J Affect Disord. 2005 Dec;89(1-3):137-46
pubmed: 16274750
Annu Rev Clin Psychol. 2010;6:109-38
pubmed: 20192788
J Psychiatr Res. 2011 Feb;45(2):262-8
pubmed: 20609450
J Clin Psychiatry. 2008 Apr;69(4):621-32
pubmed: 18363421
Z Evid Fortbild Qual Gesundhwes. 2018 Apr;131-132:28-37
pubmed: 29544715
J Clin Psychiatry. 2008 Mar;69(3):418-24
pubmed: 18278989
Depress Anxiety. 2006;23(4):245-9
pubmed: 16688739
J Consult Clin Psychol. 2014 Apr;82(2):287-97
pubmed: 24447004